- 24 h
- letzte 200 News
| Zeit | Aktuelle Nachrichten | ||
|---|---|---|---|
| 03.12. | Bridging gaps and breaking barriers in pharma alliances | ||
| 02.12. | MHRA urges companies to prepare for Windsor Framework for medicines | ||
| 02.12. | Merck shares positive phase 3 results for pulmonary arterial hypertension therapy | ||
| 02.12. | Enabling a sustainable and mutually beneficial CDMO partnership | ||
| 29.11. | UK researchers uncover first new asthma and COPD attack treatment in 50 years | ||
| 29.11. | GSK granted EC approval for meningococcal disease vaccine Menveo | ||
| 29.11. | Galderma announces positive late-stage results for nemolizumab in prurigo nodularis | ||
| 29.11. | Health equity: what will you do? | ||
| 28.11. | AstraZeneca announces positive results for Truqap in phase 3 prostate cancer study | ||
| 28.11. | BeiGene's Tevimbra approved by EC for first-line gastric and oesophageal cancer use | ||
| 28.11. | Sanofi opens €558m modular concept manufacturing facility in Singapore | ||
| 28.11. | How the 'five Ps' can close health equity gaps | ||
| 27.11. | Novartis' Kisqali granted EC approval to treat early breast cancer patients | ||
| 27.11. | GSK's linerixibat shows promise in phase 3 primary biliary cholangitis trial | ||
| 27.11. | FDA approves Shorla Oncology's Imkeldi to treat leukaemia and other cancers | ||
| 27.11. | All hands on deck | ||
| 26.11. | Roche expands cell therapy capabilities with $1.5bn Poseida acquisition | ||
| 26.11. | AstraZeneca announces $3.5bn US investment to boost research and manufacturing | ||
| 26.11. | Ipsen shares positive three-year results for Iqirvo in primary biliary cholangitis | ||
| 26.11. | Langland appoints Gemma Cathcart as managing partner | ||
| 26.11. | Why the patient voice is the secret to re-energising the healthcare sector | ||
| 25.11. | Novartis and Ratio enter radiotherapeutics partnership worth $745m | ||
| 25.11. | J&J and Protagonist share promising phase 3 results for icotrokinra in plaque psoriasis | ||
| 25.11. | FDA approves BridgeBio Pharma's Attruby to treat rare heart disease ATTR-CM | ||
| 25.11. | Delivering real value through live meetings: the power of interactive formats |
Sie erhalten auf FinanzNachrichten.de kostenlose Realtime-Aktienkurse von und .
